Skip to main content
Iranian Biomedical Journal logoLink to Iranian Biomedical Journal
. 2024 Dec 5;29(1-2):57–67. doi: 10.61186/ibj.4567

Antioxidant Potentials, Protease Inhibitory, and Cytotoxic Activities of Various Isolated Extracts from Salvia aegyptiaca

Ali Hosseini 1,2, Mahmoodreza Moein 1,2,*, Zahra Sabahi 2,*, Soheila Moein 2, Salar Hafez Ghoran 3, Moslem Naderian 1,2, Zahra Zebarjad 2
PMCID: PMC12040637  PMID: 40223459

Abstract

Background:

Natural compounds can regulate the growth and progression of cancer cells with low toxicity to normal cell; therefore, these compounds are unique targets for cancer treatment. Recently, extracts from Salvia species have shown promising antiproliferative potential. This study aimed to isolate and characterize bioactive compounds from S. aegyptiaca and evaluate their antioxidant, cytotoxic, and protease-inhibitory activities.

Methods:

In this study, various extracts of S. aegyptiaca were prepared, and several compounds, including ursolic acid, oleanolic acid, luteolin-7-O-glucoside, quercetin-3-O-rutoside, and rosmarinic acid, were isolated and characterized using different spectroscopic methods. Finally, the antioxidant activity, protease inhibitory activity, and cytotoxicity of the crude extract, multiple fractions, and isolated compounds were examined.

Results:

According to the results obtained, rosmarinic acid demonstrated the highest antioxidant performance, as indicated by the following assays: DPPH (IC50: 28.39 ± 0.75 µg/mL), ABTS (39.52 ± 0.72 µg/mL), FRAP (31.87 ± 0.67 µg/mL), NO scavenging (71.44 ± 1.04 µg/mL), and ORAC values (0.6 TE/mg). Furthermore, both cynaroside and rosmarinic acid exhibited the most potent antiproliferative effects against the Hep G2 cell line, with IC50 value of 34.4 ± 2.34 and 47.84 ± 5.87 µg/mL, respectively. The EtOAc fraction and rosmarinic acid also showed higher protease inhibitory activity, with IC50 of 17.6 ± 0.10 and 17.0 ± 0.30 µg/mL, respectively, as compared to other compounds.

Conclusion:

Our findings suggest that the identified compounds may be responsible for the antiproliferative effects of S. aegyptiaca. Overall, S. aegyptiaca could serve as a valuable natural antioxidant and anticancer agent in both pharmaceutical and food industries.

Key Words: Antioxidants, Salvia, Protease inhibitors, Hep G2 cell line

INTRODUCTION

Cancer, a disease with a high mortality rate, poses a significant threat to human health. The urgency for more effective treatments is underscored by its severity. Medicinal plants, known for their potent anticancer and antiproliferative properties, represent a promising avenue for the discovery of cancer therapies. Most anticancer drugs, currently used in the clinical settings are natural products of plant origin[1]. Between 1981 and 2014, 52% of all approved molecules for cancer treatment were either natural products or their derivatives, including paclitaxel, docetaxel, vincristine, cabazitaxel, and romidepsin, highlighting the importance of plant sources in the research for effective cancer therapies[2].

A significant factor influencing cancer incidence is the presence of free radicals, which are generated through normal metabolic processes and external factors such as air pollution and ultraviolet radiation. Free radicals are reactive molecules that can efficiently interact with proteins, lipids, and nucleic acids. This interaction can result in cellar damage and increase in the risk of various diseases, including cancer, diabetes, heart and neurodegenerative diseases[3]. Antioxidants, particularly those derived from plant sources, offer a promising strategy for protecting cells against free radical damage. These natural antioxidants, known for their lower toxicity and potential health benefits, have garnered significant attention in recent researches[4,5].

Salvia, one of the largest and most valuable genera within the Lamiaceae family, is a treasure trove of biological properties. With over 1,000 species found worldwide, Salvia plants have been recognized for their diverse biological activities, including anticancer, antioxidant, antidiabetic, antimicrobial, anti-inflammatory, and neuroprotective properties[6-9]. Phytochemical analyses have revealed that Salvia species are rich in various chemical compounds, including phenolic acids, phenolic glycosides, flavonoids, anthocyanins, polysaccharides, terpenoids, and coumarins. This diversity of compounds contributes to the antioxidant and anticancer properties of Salvia plants, making them a fascinating subject for further study[7]. The antioxidant properties of Salvia extracts are primarily attributed to the presence of phenolic compounds[3]. Furthermore, Salvia species exhibit antibacterial activity and inhibitory effects on acetylcholinesterase, butyrylcholinesterase, α-glucosidase, β-glucosidase, β-glucuronidase, and tyrosinase[4].

Salvia aegyptiaca is a green dwarf plant belonging to the Tubiflorales class, Verbenales (Lamiaceae) phylum, Labiatae family, and Salvia genus. This species grows in various regions of the Arabian Peninsula, Egypt, Palestine, Iran, and Afghanistan. In Iran, it is primarily found in southern parts of the country, especially in Hormozgan Province. S. aegyptiaca has a rich history of application in traditional medicine, where it is valued for its sedative and antiseptic properties and its effectiveness in treating diarrhea, nervous disorders, vertigo, and tremors[5,7,8].

In this study, we employed the LLE method, along with various mixtures of organic solvents to fractionate the air-dried aerial parts of S. aegyptiaca. We subsequently used 1H-NMR and 13C-NMR spectroscopy to identify the chemical structures of five isolated compounds (1-5). The antioxidant potential of these compounds was assessed using DPPH, ABTS, FRAP, ORAC, and NO assays. Furthermore, we investigated the protease inhibitory activities and cytotoxic effects of the extracted compounds against the Hep G2 cell line.

MATERIALS AND METHODS

Chemicals

DPPH, quercetin, ABTS, and TPTZ were acquired from Sigma-Aldrich, Germany. The solvents used in the present study, including MeOH, CHCl3, EtOAc, n-BuOH, and petroleum ether, were commercially purchased from Merck Chemical Co. (Germany). All chemicals and reagents were applied without any further purification. TLC sheets (20 × 20 cm; pre-coated silica gel 60 F254; Merck) were used for analytical TLC, and spot detection was performed using an anisaldehyde/sulfuric acid reagent, followed by heating. Column chromatography was conducted with silica gel (70-230 and 230-400 mesh; Merck). For all assays, we used standard 96-well microplates.

Plant material

S. aegyptiaca aerial parts were randomly collected from Geno Mountain (Hormozgan, Iran) in March 2017. The voucher sample was deposited in the Medicinal Processing Research Center, Shiraz, Iran, herbarium under code MPPRC-93-2.

Extraction and isolation procedures of S. aegyptiaca

The air-dried aerial parts of S. aegyptiaca (3.4 kg) were powdered and macerated (drenching) in 70% hydroethanolic solvent (24 L × 48 h × 3). Afterwards, ethanol was removed under vacuum using a rotary evaporator to achieve 0.9 kg of dark green gummy extract. Subsequently, the crude extract (400 g) was dissolved in 1,000 mL of distilled water. The crude extract was successively fractionated using the LLE method and various solvents, including petroleum ether, CHCl3, EtOAc, and n-BuOH, to obtain the compounds 1-5. The mixture of compounds 1 and 2 was obtained after washing with acetone. Then, 6 g of CHCl3 fraction was subjected to an open silica gel (200 g; 70-230 mesh) column chromatography (3.5 cm × 40 cm) and eluted with a gradient system of n-hexane-EtOAc-MeOH to obtain 85 SFrs. Having developed the TLC of SFrs and checked them under UV light at 254 and 365 nm by using a vanillin/sulfuric acid reagent, the similar SFrs were collected with the final six fractions (FrA-FrF). FrB (411 mg) was re-chromatographed on a flash silica column (2 cm × 20 cm) and washed with CHCl3-acetone (6:4), in which 35 SFrs were obtained. SFrs 24-31 afforded compound 3 (17 mg). FrE (1310 mg) was submitted to another flash silica column (2 cm × 25 cm) and eluted with EtOAc-acetone (70:30), in which 55 SFrs were obtained. SFrs 18-27 and SFrs 30-36 yielded compounds 4 (13 mg) and 5 (15 mg).

NMR spectroscopy

The 1H-NMR and 13C-NMR spectra of isolated compounds 1-5 were recorded on a Bruker BioSpin GmbH 300 spectrometer (Germany). The 1H-NMR and 13C-NMR spectra of the isolated compounds 1-5 were recorded on a Bruker BioSpin GmbH 300 MHz NMR spectrometer (Germany), equipped with a 5 mm multinuclear probe. The 1H-NMR spectra were obtained at a frequency of 300 MHz, while the 13C-NMR spectra were recorded at a frequency of 100 MHz. The spectra were acquired with the standard acquisition parameters for each nucleus at room temperature. CDCl3 was used as the solvent, and tetramethylsilane as the internal standard. Chemical shifts (δ) are expressed in ppm and coupling constants (J) in Hz.

DPPH radical scavenging activity assay

The DPPH assay was carried out using a previously described method[3]. Briefly, 200 µL of methanolic DPPH solution was mixed with 20 µL of tested samples at various concentrations (6.25-3200 μg∕mL) in a 96-well microplate. Then, the microplate was placed in a dark condition at 37 °C for 30 min, and after that, the absorbance was measured at 517 nm with a microplate reader (Biotek, USA). In this assay, quercetin was used as the standard. The blank wells contained 20 μL of extracts and 200 μL of MeOH, and the control wells contained 20 μL of MeOH and 200 μL of DPPH solution. The experiments were repeated in triplicate for each sample. The percentage of DPPH scavenging activity of each extract was calculated using the following formula: % inhibition = 100 – (absorption sample – [absorption control/absorption blank]) ×100.

ABTS assay

The ABTS radical cation (ABTS+•) was generated by mixing 5 mL of ABTS diammonium salt aqueous solution with 5 mL of ammonium persulfate solution. The obtained mixture was kept in the dark at room temperature for 16 hours before use. The ABTS+• solution was diluted with ethanol to an absorbance of 0.70 ± 0.05 at 734 nm. Then, 200 µL of ABTS+• radical cation solution was added to 20 µL of different concentrations of samples in a 96-well microplate. Finally, the absorbance was determined at 734 nm after 15 minutes.

FRAP assay

The FRAP capacity of fractions and extracted compounds 1-5 to reduce Fe 3+ to Fe 2+ was assessed based on the Benzie method[5]. The FRAP reagent was freshly prepared by mixing acetate buffer (300 mM; pH 3.6), TPTZ (10 mM) in 40 mM of HCl, and 20 mM of FeCl3.6H2O in a ratio of 10:1:1 (v/v). The FRAP reagent was placed in the dark at 37 °C for 10 minutes before use. The experiment was conducted in a 96-well plate. Briefly, 20 μL of different concentrations of each extract (6.25-3200 μg∕mL) was added to 180 μL of freshly prepared and pre-warmed (37 °C) FRAP solution in test wells. Control wells contained 20 μL of MeOH and 180 μL of FRAP solution. The absorbance of samples was measured at 593 nm using a microplate reader (Biotek), and the following formula calculated the FRAP values: FRAP value = (absorption control-[absorption sample/absorption control]) × 100.

NO radical scavenging

The Griess-Ilosvay reaction using sodium nitroprusside was utilized to determine the NO radical scavenging activity of the various fractions of crude extract and isolated compounds from S. aegyptiaca. In general, 50 µL of sodium nitroprusside (10 mmol) and 50 µL of MeOH were mixed and added to 50 µL of the S. aegyptiaca species solution. The blank containing 50 µL of extract, 50 µL of sodium nitroprusside and 50 µL of MeOH was considered as control wells. The microplate was then incubated at 25 °C for 150 min. Subsequently, 100 µL of Griess reagent was added to each well, except for blanks, and incubated at room temperature for 5 min. Finally, the absorption was read at 542 nm. The following formula was used to achieve the relative inhibition ratio for each compound[5,6]: inhibition ratio = (absorptionsample-[Absorption blank/absorption control]) × 100.

ORAC assay

The oxygen radical scavenging efficacy of the crude extract, various fractions, and isolated compounds from S. aegyptiaca. were measured using the ORAC assay. Briefly, a mixture of 20 µL of blank, Trolox standard, or samples in potassium phosphate buffer (75 mM) was prepared and added to a 96-well microplate in triplicates. A 200 µL of 0.96 µM fluorescein in working buffer was added to each well and incubated at 37 °C for 20 min. Then, the fluorescein solution of AAPH was added, and the fluorescence decay at 538 nm was measured with excitation at 485 nm every 4.5 min for 2.5 h using the polar star omega device. The ORAC values were defined as TE[4,5].

CAA assay

The Hep G2 cells were seeded at a density of 6 × 104 cells/well on a 96-well microplate overnight. Then, the growth medium was discarded, and each well was washed with PBS in triplicate. The wells were treated with 100 µL of treatment medium containing different concentrations of S. aegyptiaca extracts plus 25 µM of DCFH-DA and incubated at 37 °C. After incubation, the liquid was removed, and the wells were washed with 100 µL of PBS. Finally, an AAPH (free radical initiator) solution was applied to the cells, and the microplate was placed in a polar star omega device at 37 °C. The emission at 538 nm was read after excitation at 485 nm every 5 min for one hour. The IC50 values for all samples and quercetin as a standard drug were determined at concentrations for scavenging 50% of AAPH radicals[5].

Cell lines and MTT cytotoxic assay

The growth inhibitory effect of the crude extract, various fractions, and isolated compounds from S. aegyptiaca on the hepatocellular carcinoma (Hep G2; the Pasteur Institute of Iran) cell line was evaluated using the MTT calorimetry method. Briefly, Hep G2 cells with a density of 10,000 cells/well were seeded in a 96-well microplate in a 5% CO2 incubator at 37 °C. After incubation for 24 h, cells were treated with crude extract and obtained fractions of S. aegyptiaca at 12.5-200 μg/mL concentrations. Subsequently, after 24 h, the medium was aspirated, and then 150 μL of MTT solution was added to each well, followed by incubation in a 5% CO2 incubator at 37 °C for 4 hours. The produced formazan crystals were solubilized in DMSO. The optical density of each well was read using an ELISA reader at a wavelength of 570 nm[7]. The IC50 values were obtained by plotting the percentage of 50% growth inhibition versus concentration. The data are presented as the mean ± SD for each analysis.

Determination of protease inhibition

Different concentrations of S. aegyptiaca (1-300 µg/mL) were prepared. In brief, 200 μL of phosphate buffer (50 mM) was combined with 50 μL of each concentration of the samples to evaluate the inhibitory activity against the protease enzyme. Subsequently, 200 μL of protease and 400 μL of casein (1%) as a substrate were added to the mixture. It was then allowed to incubate at 25 ºC for 10 minutes. 800 μL of trichloroacetic acid (10%) was added to the mixture as the stopper of the reaction. After a 21-minute interval, the mixture was centrifuged (Peco, Iran) at 895 ×g for 5 minutes. A UV-Vis spectrophotometer (PG instrument T90, England) was used to read the absorbance of the supernatant at 280 nm[8].

Statistical analysis

The obtained values were statistically analyzed using SPSS and Excel 2013 software. The IC50 values were expressed as mean ± SD, the mean of three replicates.

RESULTS

Spectroscopic data

The chemical structures of five extracted compounds from S. aegyptiaca, including ursolic acid (1), oleanolic acid (2), luteolin-7-O-glucoside (3), quercetin-3-O-rutoside (4), and rosmarinic acid (5) (Fig. 1), were confirmed using NMR spectroscopy. The ' 1H-NMR and 13C-NMR spectra showed signals corresponding to their structures.

Fig. 1.

Fig. 1

Chemical structures of the isolated compounds from S. aegyptiaca extracts. Ursolic acid (1), oleanolic acid (2), luteolin-7-O-glucoside (3), quercetin-3-O-rutoside (4), and rosmarinic acid (5).

Compound 1 (Ursolic acid): 1H-NMR (300 MHz, DMSO-d6): δH 12.07 (1H, brs, 28-COOH), 5.15 (1H, m, H-12), 4.33 (1H, d, J = 3.9 Hz, OH-3), 2.99 (1H, brs, H-3), 2.10 (1H, d, J = 10.5 Hz, H-18), 1.03 (3H, s, Me-27), 0.91 (3H, m, Me-30), 0.89 (3H, s, Me-23), 0.86 (3H, s, Me-25), 0.81 (3H, d, J = 6.5 Hz, Me-29), 0.74 (3H, s, Me-26), 0.67 (3H, s, Me-24). 13C-NMR (75 MHz, DMSO-d6): δC 178.66 (C-28), 138.23 (C-13), 124.62 (C-12), 76.86 (C-3), 54.82 (C-5), 52.40 (C-18), 47.09 (C-9), 46.86 (C-17), 41.75 (C-14), 38.55 (C-4), 38.43 (C-20 & C-8), 38.26 (C-10), 36.58 (C-1), 32.89 (C-21), 32.74 (C-7), 30.46 (C-19), 30.22 (C-22), 28.31 (C-23), 27.53 (C-15), 27.02 (C-2), 23.85 (C-16), 23.41 (C-27), 22.95 (C-11), 21.14 (C-30), 18.06 (C-6), 17.08 (C-29), 16.95 (C-26), 16.15 (C-24), 15.28 (C-25)(3, 4).

Compound 2 (Oleanolic acid): 1H-NMR (300 MHz, DMSO-d6): δH 12.06 (1H, brs, 28-COOH), 5.15 (1H, m, H-12), 2.99 (1H, brs, H-3), 2.73 (1H, d, J = 13.7, 4.6 Hz, H-18), 1.90 (1H, m, H16a), 1.82 (2H, m, H-11a & H-11b), 1.09 (3H, s, Me-27), 0.91 (3H, m, Me-30), 0.89 (3H, s, Me-23), 0.86 (3H, s, Me-25), 0.85 (3H, s, Me-29), 0.74 (3H, s, Me-26), 0.67 (3H, s, Me-24). 13C-NMR (75 MHz, DMSO-d6): δC 178.36 (C-28), 143.87 (C-13), 121.56 (C-12), 76.86 (C-3), 54.52 (C-5), 40.83 (C-18), 46.86 (C-9), 45.71 (C-17), 45.49 (C-19), 41.35 (C-14), 38.26 (C-8), 38.09 (C-4), 36.58 (C-1), 33.35 (C-10), 32.89 (C-21), 32.45 (C-29), 32.13 (C-7), 30.46 (C-22), 30.22 (C-20), 28.28 (C-23), 27.24 (C-15), 27.02 (C-2), 25.65 (C-27), 23.41 (C-30), 22.95 (C-16), 22.64 (C-11), 18.05 (C-6), 16.88 (C-26), 16.09 (C-24), 15.16 (C-25)[4,5].

Compound 3 (Luteolin-7-O-glucoside): 1H-NMR (300 MHz, DMSO-d6): δH 12.99, (1H, s, 5-OH), 7.45 (1H, dd, J = 8.3, 2.2 Hz, H-6’), 7.42 (1H, d, J = 2.0 Hz, H-2’), 6.90 (1H, d, J = 8.3 Hz, H-5’), 6.79 (1H, d, J = 2.1 Hz, H-8), 6.76 (1H, s, H-3), 6.45 (1H, d, J = 2.0 Hz, H-6), 5.08 (1H, d, J = 7.1 Hz, H-1’’), 3.71 (1H, brd, J = 10.1 Hz, H-6’’a), 3.15-3.49 (5H, m, H2’’, H-3’’, H-4’’, H-5’’, H-6’’b). 13C-NMR (75 MHz, DMSO-d6): δC 181.98 (C-4), 164.53 (C-2), 163.00 (C-7), 161.20 (C-5), 157.01 (C-8a), 150.01 (C-4’), 145.85 (C-3’), 121.42 (C-1’), 119.25 (C-6’), 116.04 (C-5’), 113.60 (C-2’), 105.39 (C-4a), 103.22 (C-3), 99.90 (C-1’’), 99.58 (C-6), 94.77 (C-8), 77.21 (C-5’’), 76.43 (C-3’’), 73.16 (C-2’’), 69.57 (C-4’’), 60.65 (C-6’’)[6,7].

Compound 4 (Quercetin-3-O-rutoside): 1H-NMR (300 MHz, DMSO-d6): δH 12.60, (1H, s, 5-OH), 7.54 (1H, dd, J = 7.4, 1.9 Hz, H-6’), 7.52 (1H, d, J = 1.9 Hz, H-2’), 6.84 (1H, d, J = 8.7 Hz, H-5’), 6.38 (1H, d, J = 1.9 Hz, H-8), 6.19 (1H, d, J = 1.9 Hz, H-6), 5.34 (1H, d, J = 7.1 Hz, H-1’’), 4.37 (1H, brs, H-1’’’), 3.70 (1H, brd, J = 9.8 Hz, H-6’’a), 3.00-3.72 (9H, m, sugar H-2’’, H-3’’, H-4’’, H-5’’, H-6’’b, H-2’’’, H-3’’’, H-4’’’, H-5’’’), 0.98 (1H, d, J = 6.1 Hz, H-6’’’). 13C-NMR (75 MHz, DMSO-d6): δC 177.42 (C-4), 164.19 (C-7), 161.27 (C-5), 156.67 (C-2), 156.48 (C-8a), 148.48 (C-4’), 144.82 (C-3’), 133.34 (C-3), 121.65 (C-6’), 121.22 (C-1’), 116.31 (C-2’), 115.28 (C-5’), 104.00 (C-8), 101.22 (C-1’’), 100.82 (C-1’’’), 98.75 (C-4a), 93.66 (C-6), 76.48 (C-3’’), 75.95 (C-5’’), 74.12 (C-2’’), 71.88 (C-4’’’), 70.60 (C-3’’’), 70.43 (C-2’’’), 70.04 (C-4’’), 68.32 (C-5’’’), 67.06 (C-6’’), 17.81 (C-6’’’)[8].

Compound 5 (Rosmarinic acid): 1H-NMR (300 MHz, DMSO-d6): δH 7.38 (1H, d, J = 15.8 Hz, H-7), 7.05 (1H, d, J = 2.0 Hz, H-1), 6.94 (1H, dd, J = 8.2, 2.0 Hz, H-5), 6.75 (1H, d, J = 8.1 Hz, H-4), 6.67 (1H, d, J = 2.0 Hz, H-18), 6.61 (1H, d, J = 8.0 Hz, H-15), 6.50 (1H, dd, J = 8.0, 2.0 Hz, H-14), 6.20 (1H, d, J = 15.9 Hz, H-8), 4.89 (1H, d, J = 9.9, 3.2 Hz, H-10), 3.02 (1H, dd, J = 14.4, 3.1 Hz, H-12a), 2.77 (1H, dd, J = 14.3, 10.0 Hz, H-12b). 13C-NMR (75 MHz, DMSO-d6): δC 172.82 (C-11), 166.31 (C-9), 148.64 (C-3), 145.91 (C-2), 145.00 (C-17), 144.68 (C-7), 143.71 (C-16), 129.55 (C-13), 125.57 (C-6), 121.09 (C-5), 119.82 (C-14), 116.70 (C-4), 116.03 (C-8), 115.43 (C-18), 115.06 (C-15), 114.62 (C-1), 75.54 (C-10), 37.11 (C-12)[9].

Results of antioxidant activity

According to the studies, oxidative stress arising from disruptions in the production of reactive oxygen species during metabolic processes, involves in many pathologies, including cancer, cardiovascular diseases, neurodegenerative diseases, and skin disorders[10,11]. The antioxidant properties of plant products with less toxicity are an essential strategy for protecting organisms against the harmful effects of free radicals[12,13]. The antioxidant capacity of plants is attributed to their phenolic compounds, which can easily donate electrons and hydrogen atoms due to their highly conjugated systems and aromatic structures[14-16]. Thus, the five extracted compounds 1-5 were evaluated for their antioxidant capacity using the DPPH, ABTS, FRAP, ORAC, and NO assays. The obtained antioxidant results are expressed as IC50 values (µg/mL) and represented in Table 1. As demonstrated in this table, the significant antioxidant activity of S. aegyptiaca extracts is impressive and piques further scientific interest.

Table 1.

Antioxidant activities of S. aegyptiaca extracts and fractions

Extracts and compounds DPPH
IC 50 (μg/mL)
ABTS
IC 50 (μg/mL)
FRAP
IC 50 (μg/mL)
NO scavenging ability percentage (200 μg/mL) ORAC
TE
Crude extract 72.68 ± 0.77 78.71 ± 0.56 84.10 ± 0.84 41.8 ± 0.018 0.41
Petroleum ether Fr 1036.38 ± 3.48 585.77 ± 3.59 339.15 ± 4.87 52.01 ± 0.029 0.17
CHCl3 Fr 252.14 ± 1.62 236.44 ± 2.48 245.52 ± 3.23 36.89 ±.52 0.25
EtOAc Fr 121.33 ± 1.77 158.51 ± 1.41 185.63±1.69 59.37 ± 0.81 0.77
n-BuOH Fr 136.12 ± 1.45 143.13 ± 1.64 175.38 ± 1.64 48.77 ± 0.67 0.51
Ursolic acid >2000 >2000 298.51 ± 1.76 55.52 ± 0.43 0.31
Oleanolic acid >2000 >2000 198.86 ± 1.49 48.82 ± 0.91 0.46
Cynaroside 36.37 ± 1.07 112.92 ± 1.10 46.88 ± 0.83 67.7 ± 0.02 0.95
Rutin 33.48 ± 0.52 87.31 ± 0.68 42.62 ± 0.86 81.30 ± 0.37 0.83
Rosmarinic acid 28.39 ± 0.75 39.52 ± 0.72 31.87 ± 0.67 71.44 ± 1.04 0.60
Quercetins 26.51 ± 0.06 26.35 ± 0.03 18.53 ± 0.12 89.96 ± 0.01 1.06

Each value is the mean ± SD of triplicate analysis.

Results of DPPH scavenging activity

The DPPH assay is one of the most popular and well-established spectrophotometric methods commonly used to measure the free radical scavenging activity of  plant extracts and isolated pure compounds. In this assay, a stable free radical, DPPH, is reduced by antioxidant agents. The antioxidant activity was measured based on the color change from purple to yellow and the corresponding absorption changes occurring at a wavelength of 517 nm[1,17,18]. The DPPH radical scavenging activities of the fractions and extracted compounds 1-5, as well as quercetin as a standard compound, were measured, and the obtained results are shown in Table 2. According to the results, cynaroside, rutin, and rosmarinic acid exhibited the highest radical scavenging activities with IC50 values of 36.37 ± 1.07, 33.48 ± 0.52, and 28.39 ± 0.75 µg/mL, respectively, which were comparable to quercetin with an IC50 value of 26.51 ± 0.06 µg/mL. Meanwhile, ursolic and oleanolic acids showed no significant scavenging activities (IC50 > 2,000 µg/mL). The crude extract with an IC50 value of 72.68 ± 0.77 μg/mL exhibited higher scavenging activity than the fractions. In general, the scavenging activities of the fractions were moderate. It was observed that the EtOAc and n-BuOH fractions with IC50 values of 121.33 ± 1.77 and 136.12 ± 1.45 μg/mL, respectively, exhibited higher DPPH scavenging activities compared to that of the CHCl3 fraction with IC50 value of 252.14 ± 1.62 μg/mL. The petroleum ether fraction showed weak scavenging activity (IC50 = 1036.38 ± 3.48). The order of DPPH scavenging activity of fractions was as follows: crude extract > EtOAc > n-BuOH > CHCl3 > petroleum ether (Table 1).

Table 2.

In vitro cytotoxic and protease inhibitory activity (IC50, μg/mL) of extracts and compounds isolated from S. aegyptiaca extracts

Extracts and compound Hep G2 cells
IC 50 (μg/mL)
CAAIC 50 (μg/mL) Protease inhibition
IC 50 (μg/mL)
Crude extract >200 70.45 ± 1.10 23.3 ± 0.5
Petroleum ether Fr >200 >200 28.1 ± 0.2
CHCl3Fr 123.45 ± 8.85 123.69 ± 0.24 228.0 ± 0.4
EtOAc Fr 41.47 ± 2.12 126.15 ± 2.38 17.6 ± 0.1
n-BuOH Fr 89.38 ± 7.34 >200 26.2 ± 0.3
Ursolic acid >200 183.81 ± 9.25 24.5 ± 0.1
Oleanolic acid 123.43 ± 8.84 >200 28.0 ± 0.2
Cynaroside 34.4 ± 2.34 174.41 ± 2.5 23.8 ± 0.1
Rutin 63.91 ± 0.96 >200 22.4 ± 0.1
Rosmarinic acid 47.84 ± 5.87 171.33 17.0 ± 0.3
Quercetins ND 38.94 ± 0.87 ND
Cisplatin 12.65 ± 0.78 ND ND
Iodoacetamideb ND ND 10.6 ± 0.5

ND: not detected; scontrol for CAA test, a positive control for cytotoxicity against Hep G2 cell lines; bpositive control for anti-protease activity.

ABTS+• scavenging activity findings

The antioxidant capacity of the isolated compounds 1-5 and fractions was assessed through ABTS assay. In this assay, rosmarinic acid showed the highest activity with an IC50 value of 39.52 ± 0.72 μg/mL, followed by rutin (IC50 = 87.31 ± 0.68 μg/mL) and cymaroside IC50 = 112.92 ± 1.10 μg/mL). On the contrary, similar to the DPPH assay, ursolic and oleanolic acids exhibited no significant ABTS activity (IC50 > 2000 µg/mL). Furthermore, the crude extract (IC50 = 78.71 ± 0.56 μg/mL) showed higher ABTS+• scavenging activity than the other fractions. Among the fractions, the n-BuOH fraction had the highest ABTS+• scavenging activity (IC50 = 143.13 ± 1.64 μg/mL), while the lowest values were observed for petroleum ether and CHCl3 fractions (Table 1).

FRAP scavenging activity findings

Cynaroside, rutin, and rosmarinic acid showed good antioxidant activity, as observed in the DPPH radical scavenging assay. Rosmarinic acid exhibited the best FRAP activity with an IC50 value of 31.87 ± 0.67 μg/mL, which is relatively comparable to quercetin. Rutin indicated an IC50 value of 42.62 ± 0.86 μg/mL, followed by cynaroside with IC50 = 46.88 ± 0.83 μg/mL. On the other hand, among the extracts, ursolic acid (IC50 = 298.51 ± 1.76 μg/mL) and oleanolic acid (IC50 = 198.86 ± 1.49 μg/mL) exhibited moderate FRAP activity. Furthermore, the crude extract displayed significant antioxidant potential with an IC50 value of 84.10 ± 0.84 μg/mL, while the others showed the IC50 values ranging from 175.38 to 339.15 μg/mL. Differences in FRAP activities could be related to various phenolic content of the extracted compounds (Table 1).

Radical scavenging activity outcomes

The scavenging efficiency of crude extract, fractions, and isolated compounds (1-5) from the aerial parts of S. aegyptiaca was evaluated and compared with quercetin as a standard agent. The results clearly showed that the activity of rutin was comparable to that of quercetin at a concentration of 200 μg/mL. Rosmarinic acid and cynaroside could scavenge NO radicals with 71.44 ± 0.37 % and 67.7 ± 0.02% at 200 μg/mL concentration, respectively. However, ursolic and oleanolic acids inhibited NO inhibition with 55.52% and 48.82%, respectively. The order of NO-scavenging capacity of the fractions is ethyl acetate > petroleum ether > n-butanol > chloroform; therefore, the EtOAc fraction had the highest NO scavenging percent with 59.37 ± 0.37 % among the fractions (Table 1). These NO scavenging outputs support the antioxidant and anti-inflammatory activities of extracts of S. aegyptiaca. The phytochemical analysis of S. aegyptiaca showed the presence of rutin, cynaroside, and rosmarinic acid in the EtOAc fraction, which are associated with NO scavenging action in biological systems[19].

ORAC test results

This assay is widely used to assess the antioxidant capacity of a compound. It measures the ability of a sample to neutralize oxygen free radicals, which are reactive molecules associated with oxidative stress and various diseases. In the ORAC test, a fluorescent probe sensitive to oxidation is used in the presence of free radicals generated by thermal reaction. As antioxidants in the sample react with the radicals, the fluorescence decay is monitored, providing a quantitative measure of the antioxidant capacity. The higher the ORAC value, the greater the antioxidant potential of the tested compound, indicating its ability to protect against oxidative damage. Cynaroside (0.95 TE) and rutin (0.83 TE) showed significant ORAC effects, followed by rosmarinic acid (0.60 TE). Furthermore, the ORAC activity of the EtOAc fraction (0.77 TE) was higher than that of the crude extract and other fractions (Table 1).

CAA Results

The CCA assay, a key component of our study, measures the antioxidant activity in the cell culture. It is based on the interaction between the tested extract and complex enzymatic reactions in a biological system, representing a more relevant physiological/biological importance[20]. The outcomes of CCA values for the S. aegyptiaca fractions and isolated compounds are illustrated in Table 2. Interestingly, the most potent CCAs were observed for the crude extract. The order of the CAA activities is as follows: chloroform > ethyl acetate > petroleum ether and n-BuOH fractions. The IC50 values for all tested compounds were not remarkable. The IC50 values of all sub-fractions were higher than 170 μg/mL.

Evaluation of cytotoxic activity

The cytotoxic activity of five isolated compounds (1-5) from S. Aegyptiaca and different fractions is depicted in Figure 2. Remarkably, the crude extract showed no cytotoxic effect on the Hep G2 cell line, nor did the petroleum ether fraction. Among the various fractions, distinct differences in cytotoxic potential were observed. The EtOAc fraction demonstrated the highest cytotoxic activity with IC50 = 41.47 ± 2.12 μg/mL. At the same time, moderate growth inhibition was obtained for the n-BuOH and CHCl3 fractions. The different cytotoxicity suggests the presence of various compounds in their fractions. On the other hand, a comparative study of the isolated compounds revealed that cynaroside was the most cytotoxic compound with IC50 value of 34.4 ± 2.34 μg/mL, and also, rosmarinic acid and rutin exhibited moderate activity with IC50 of 47.84 ± 5.87 and 63.91 ± 0.96 μg/mL, respectively. Oleanolic acid showed a low antiproliferative effect on the Hep G2 cells, and ursolic acid demonstrated negligible cytotoxicity on these cells, with an IC50 value greater than 200 μg/mL.

Fig. 2.

Fig. 2

In vitro cytotoxicity, cellular antioxidant (CCA), and protease inhibitory activity of fractions and isolated compounds from  S. aegyptiaca (IC50, μg/mL). Each data represent mean ± SD in triplicates.

Protease inhibitory activity

The protease inhibitory activity assay is essential for evaluating the potential therapeutic applications of the compounds. Protease inhibitors work by binding to the catalytic site of the protease, thereby preventing the cell from replicating. Table 2 demonstrates no significant differences in the protease inhibition values across all fractions and isolated compounds of S. aegyptiaca and its fractions, except for the CHCl3 fraction. Notably, the EtOAc fraction (IC50 value of 17.6 ± 0.1 μg/mL) exhibited higher activity than the other fractions, while the CHCl3 fraction showed minimal protease inhibition. Interestingly, rosmarinic acid, rutin, and cynaroside—isolated from the active ethyl acetate sub-fractions—had IC50 values of 17.0 ± 0.3, 22.4 ± 0.1, and 23.8 ± 0.1 μg/mL, respectively. Furthermore, ursolic acid and oleanolic acid demonstrated promising protease inhibition, with IC50 values of 24.5 ± 0.1 and 28.0 ± 0.2 μg/mL, respectively.

DISCUSSION

Despite significant advancements in the treatment and control of cancer, this disease remains the second leading cause of mortality and morbidity worldwide. The lack of selectivity and the undesirable side effects of available drugs have prompted ongoing research in this field. Today, treatments derived from natural products have been shown to reduce various side effects. Although only a limited number of plant-derived medicines is currently used in cancer therapy, numerous studies demonstrate the promising potential of natural compounds in vitro, which needs further examination in human trials.

Natural products and their extracts have recently gained attention as anti-proliferative agents due to their accessibility, applicability, and reduced cytotoxicity. The natural products exert their effects by modulating the cancer microenvironment and influencing various signaling pathways, including cell death pathways (apoptosis and autophagy) and embryonic developmental pathways (Notch, Wnt, and Hedgehog pathways)[21]. Different species of Salvia and their phytochemicals have shown potential applications in preventing and treating cancer with minimal side effects on normal cells. Due to its phenolic compounds, S. aegyptiaca is a valuable natural antioxidant with health-promoting properties. Several studies have reported that the DPPH radical scavenging activity and antioxidant performance of S. aegyptiaca are noteworthy[22]. In this regard, we focused on identifying the primary components of S. aegyptiaca and evaluating their antioxidant, protease inhibitory, and cytotoxic properties. Initially, the biologically active substances were isolated from S. aegyptiaca, and sub-fractions were characterized using different spectroscopic methods, including 1H-NMR and 13C-NMR. Ursolic acid and oleanolic acid were identified in the CHCl3sub-fraction. Phytochemical investigations revealed that the EtOAc sub-fraction contains flavonoids and phenolic acid compounds, including cynaroside, rutin, and rosmarinic acid. Many Salvia species are known to be rich in phenolic compounds, particularly rosmarinic acid, which confirmed our findings[22]. Antioxidant activity of the crude extract, various fractions, and isolated compounds was evaluated using six complementary tests: DPPH, ABTS, FRAP, NO radical scavenging, ORAC, and CCA.

According to the results of DPPH, ABTS, FRAP assays, cynaroside, rutin, and rosmarinic acid exhibited the highest radical scavenging activities. The DPPH scavenging activities of antioxidants are closely related to their chemical structures. Studies have shown that the presence of phenolic hydroxyl groups, with ability to donate their hydrogen or electrons to the DPPH radical, enhances the efficiency of antioxidants. Therefore, the superior DPPH scavenging activities of cynaroside, rutin, and rosmarinic acid were attributed to more phenolic hydroxyl groups in their structures. Our findings confirmed a substantial correlation between phenolic content and reducing power, which is associated with the reduction potential of plants through donating electrons or hydrogen atoms. This process leads to the termination of chain reactions by converting free radicals or reactive oxygen species into stable forms[23]. The high antioxidant activity of crude extract, ethyl acetate, and n-BuOH fractions may be attributed to many polyphenolic compounds or a high concentration of bioactive compounds in these samples. The NO scavenging data revealed that the EtOAc sub-fraction and its constitutes, especially cynaroside, rutin, and rosmarinic acid, exhibited significant antioxidant activity. The ORAC values (TE) for the EtOAc fraction and its components were 0.77, 0.95, 0.83, and 0.6 compared to quercetin, demonstrating the ability of S. aegyptiaca to scavenge alkoxyl and alkyl peroxyl radicals. Additionally, the CAA test indicated the capacity of these compounds to inhibit peroxyl radicals within cells. The results showed that all compounds exhibited substantial antioxidant activity. Notably, S. aegyptiaca contains both hydrophobic and hydrophilic constituents, with water-soluble phenolic acids responsible for the antioxidant activities observed in the EtOAc extract. These findings support and confirm other antioxidant tests. Natural compound inhibitors are bioactive molecules derived from natural sources such as plants, fungi, bacteria, or marine organisms, which can inhibit specific biological targets like enzymes, receptors, or signaling pathway. They are widely studied for their therapeutic potential in diseases such as cancer, diabetes, infections, and inflammation[24]. The findings indicate that S. aegyptiaca could inhibit the protease enzyme via its promising constituents, such as rosmarinic acid, rutin, and cynaroside. In general, the EtOAc extract contains rosmarinic acid, rutin, and cynaroside, along with semipolar analogs, including phenolic and flavonoid-like compounds. The enhanced anticancer activity of these constituents may be associated with their intracellular antioxidant activities. Chen and co-workers showed that rosmarinic acid induces apoptosis in SGC-7901 and Hep G2 cells through the mitochondrial pathway and exhibits anti-tumor effects[25]. Moreover, some studies have reported that cynaroside can inhibit the MET/AKT/mTOR signaling pathway, significantly regulate biological processes such as cell proliferation, apoptosis, autophagy, invasion, and tumorigenesis[26,27]. Lastly, rutin is an effective radical inhibitor and displays chemopreventive activity across various cancer cell lines[28]. As previously reported, flavonoids and phenolic compounds are considered potent anticancer agents due to their hydroxyl group[29]. Taken together, S. aegyptiaca represents a significant source of natural anticancer agents.

CONCLUSION

The present study investigated the antioxidant activity and cytotoxicity of the crude extract, various fractions, and five isolated compounds—ursolic acid, oleanolic acid, luteolin-7-O-glucoside, quercetin-3-O-rutoside, and rosmarinic acid— extracted from S. aegyptiaca. Our findings from antioxidant assays, including DPPH, ABTS, FRAP, ORAC, and NO, revealed the highest radical scavenging activities for cynaroside, rutin, and rosmarinic acid, which can be attributed to the presence of phenolic hydroxyl groups in their structures. These compelling results position S. aegyptiaca as a promising source of antioxidant and anticancer agents.

DECLARATIONS

Acknowledgments

No artificial intelligence services were used for the preparation of this manuscript.

Ethical approval

Not applicable.

Consent to participate

Not applicable.

Consent for publication

All authors reviewed the results and approved the final version of the manuscript.

Authors’ contributions

AH: acquisition of data, analysis and interpretation of data, drafting of the manuscript, critical revision of the manuscript for important intellectual content, statistical analysis, and administrative, technical, and material support; MM: study concept and design, administrative, technical, and material support, and study supervision; ZS: study concept and design, administrative, technical, and material support, and study supervision; SM: analysis and interpretation of data, administrative, technical, and material support; SHG: analysis and interpretation of data, drafting of the manuscript, and statistical analysis; MN: acquisition of data, drafting of the manuscript, critical revision of the manuscript for important intellectual content; ZZ: acquisition of data and statistical analysis.

Data availability

All data is provided in the manuscript.

Competing interests

The authors declare that they have no competing interests.

Funding

This study was financially supported by Shiraz University of Medical Sciences (Grant number: 98-01-05-19960).

Supplementary information

The online version does not contain supplementary material.

References

  • 1.Sevgi E, Dag A, Kızılarslan-Hançer Ç, Atasoy S, Kurt BZ, Aksakal Ö. Evaluation of cytotoxic and antioxidant potential of Dittrichia viscosa (L ) Greuter used in traditional medicine. J Ethnopharmacol. 2021;276:114211. doi: 10.1016/j.jep.2021.114211. [DOI] [PubMed] [Google Scholar]
  • 2.Majolo F, Delwing LKdOB, Marmitt DJ, Bustamante-Filho IC, Goettert MI. Medicinal plants and bioactive natural compounds for cancer treatment: Important advances for drug discovery. Phytochem Lett. 2019;31:196–207. [Google Scholar]
  • 3.Shu PH, Zhang H, Li NC, Zhang JL, Liu GW, Yang Y, et al. Natural tyrosinase inhibitors from Betula platyphylla barks. Holzforschung. 2022;76(7):674–8. [Google Scholar]
  • 4.Ghoran SH, Firuzi O, Asadollahi M, Stuppner H, Alilou M, Jassbi AR. Dammarane-type triterpenoid saponins from Salvia russellii Benth. Phytochemistry. 2021;184:112653. doi: 10.1016/j.phytochem.2020.112653. [DOI] [PubMed] [Google Scholar]
  • 5.Flores Y, Díaz C, Garay F, Colque O, Sterner O, Almanza GR. Oleanane-type triterpenes and derivatives from seed coat of Bolivian Chenopodium quinoa genotype “salar”. Rev Boliv Quím. 2005;22(1):71–7. [Google Scholar]
  • 6.Chiruvella KK, Mohammed A, Dampuri G, Ghanta RG, Raghavan SC. Phytochemical and antimicrobial studies of methyl angolensate and luteolin-7-O-glucoside isolated from callus cultures of Soymida febrifuga. Int J Biomed Sci. 2007;3(4):269–78. [PMC free article] [PubMed] [Google Scholar]
  • 7.Ghoran SH, Firuzi O, Jassbi AR. Phytoconstituents from the aerial parts of Salvia dracocephaloides Boiss and their biological activities. J Environ Treat Tech. 2020;8(4):1274–8. [Google Scholar]
  • 8.Couto JF, Simas DL, Silva MV, Barth T, Pinto SC, Tinoco LW, et al. HSCCC separations of rutin esters obtained by enzymatic reaction catalyzed by lipase. J Braz Chem Soc. 2021;32(3):523–33. [Google Scholar]
  • 9.Wang Y, Tang J, Zhu H, Jiang X, Liu J, Xu W, et al. Aqueous extract of Rabdosia rubescens leaves: forming nanoparticles, targeting P-selectin, and inhibiting thrombosis. Int J Nanomedicine. 2015;10:6905–18. doi: 10.2147/IJN.S91316. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Jaffri JM. Reactive oxygen species and antioxidant system in selected skin disorders. The Malaysian journal of medical sciences: Malays J Med Sci. 2023;30(1):7–20. doi: 10.21315/mjms2023.30.1.2. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Jomova K, Raptova R, Alomar SY, Alwasel SH, Nepovimova E, Kuca K, et al. Reactive oxygen species, toxicity, oxidative stress, and antioxidants: Chronic diseases and aging. Arch Toxicol. 2023;97(10):2499–574. doi: 10.1007/s00204-023-03562-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Luca SV, Skalicka-Woźniak K, Mihai CT, Gradinaru AC, Mandici A, Ciocarlan N, et al. Chemical profile and bioactivity evaluation of salvia species from Eastern Europe. Antioxidants. 2023;12(8):1514. doi: 10.3390/antiox12081514. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Godlewska-Żyłkiewicz B, Świsłocka R, Kalinowska M, Golonko A, Świderski G, Arciszewska Ż, et al. Biologically active compounds of plants: Structure-related antioxidant, microbiological and cytotoxic activity of selected carboxylic acids. Materials. 2020;13(19):4454. doi: 10.3390/ma13194454. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Lopez-Corona AV, Valencia-Espinosa I, González-Sánchez FA, Sánchez-López AL, Garcia-Amezquita LE, Garcia-Varela R. Antioxidant, anti-inflammatory and cytotoxic activity of phenolic compound family extracted from Raspberries (Rubus idaeus): A general review. Antioxidants. 2022;11(6):1192. doi: 10.3390/antiox11061192. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Ng ZX, Koick YTT, Yong PH. Comparative analyses on radical scavenging and cytotoxic activity of phenolic and flavonoid content from selected medicinal plants. Nat Prod Res. 2021;35(23):5271–6. doi: 10.1080/14786419.2020.1749617. [DOI] [PubMed] [Google Scholar]
  • 16.Al Aboody MS. Cytotoxic, antioxidant, and antimicrobial activities of Celery (Apium graveolens L ) Bioinformation. 2021;17(1):147–56. doi: 10.6026/97320630017147. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Ahmed NN, Al-Touby SSJ, Alrashdi YBA, Hossain MA. Isolation and characterization of cytotoxic and antioxidant biomarkers from the aerial parts of Suaeda aegyptica. Adv Biomark Sci Technol. 2024;6(1):1–7. [Google Scholar]
  • 18.Singh G, Passsari AK, Leo VV, Mishra VK, Subbarayan S, Singh BP, et al. Evaluation of phenolic content variability along with antioxidant, antimicrobial, and cytotoxic potential of selected traditional medicinal plants from India. Front Plant Sci. 2016;7:407. doi: 10.3389/fpls.2016.00407. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Adebayo SA, Ondua M, Shai L, Lebelo S. Inhibition of nitric oxide production and free radical scavenging activities of four South African medicinal plants. J Inflamm Res. 2019;12:195–203. doi: 10.2147/JIR.S199377. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Honzel D, Carter SG, Redman KA, Schauss AG, Endres JR, Jensen GS. Comparison of chemical and cell-based antioxidant methods for evaluation of foods and natural products: generating multifaceted data by parallel testing using erythrocytes and polymorphonuclear cells. J Agric Food Chem. 2008;56(18):8319–25. doi: 10.1021/jf800401d. [DOI] [PubMed] [Google Scholar]
  • 21.Hashem S, Ali TA, Akhtar S, Nisar S, Sageena G, Ali S, et al. Targeting cancer signaling pathways by natural products: Exploring promising anti-cancer agents. Biomed Pharmacother. 2022;150:113054. doi: 10.1016/j.biopha.2022.113054. [DOI] [PubMed] [Google Scholar]
  • 22.Ben Farhat M, Sotomayor JA, Jordán MJ. Antioxidants of Salvia aegyptiaca L residues depending on geographical origin. Biocatal Agric Biotechnol. 2019;1:17. [Google Scholar]
  • 23.Kamah F, Basli A, Erenler R, Bouzana A, Bensouici C, Richard T, et al. Phenolic compounds and biological activities of grape (Vitis vinifera L ) seeds at different ripening stages: insights from Algerian varieties. Arq Bras Med Vet Zootec. 2025;77(1):13361. [Google Scholar]
  • 24.Kakali B. Natural compounds as protease inhibitors in therapeutic focus on cancer therapy. Anticancer Agents Med Chem. 2024;24(16):1167–81. doi: 10.2174/0118715206303964240708095110. [DOI] [PubMed] [Google Scholar]
  • 25.Chen C, Liu Y, Shen Y, Zhu L, Yao L, Wang X, et al. Rosmarinic acid, the active component of Rubi Fructus, induces apoptosis of SGC-7901 and HepG2 cells through mitochondrial pathway and exerts anti-tumor effect. Naunyn Schmiedebergs Arch Pharmacol. 2023;396(12):3743–55. doi: 10.1007/s00210-023-02552-z. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Ji J, Wang Z, Sun W, Li Z, Cai H, Zhao E, et al. Effects of cynaroside on cell proliferation, apoptosis, migration and invasion though the MET/AKT/mTOR axis in gastric cancer. Int J Mol Sci. 2021;22(22):12125. doi: 10.3390/ijms222212125. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Sun S, Yu W, Zhang G, Li X, Song L, Lv Y, et al. Potential mechanism of traditional Chinese medicine intervention in gastric cancer: targeted regulation of autophagy. Front Pharmacol. 2025;16:1548672. doi: 10.3389/fphar.2025.1548672. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.ben Sghaier M, Pagano A, Mousslim M, Ammari Y, Kovacic H, Luis J. Rutin inhibits proliferation, attenuates superoxide production and decreases adhesion and migration of human cancerous cells. Biomed Pharmacother. 2016;84:1972–8. doi: 10.1016/j.biopha.2016.11.001. [DOI] [PubMed] [Google Scholar]
  • 29.Shah S, Narang R, Singh VJ, Pilli G, Nayak SK. A review on anticancer profile of flavonoids: Sources, chemistry, mechanisms, structure-activity relationship and anticancer activity. Curr Drug Res Rev. 2023;15(2):122–48. doi: 10.2174/2589977515666230120144852. [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Data Availability Statement

All data is provided in the manuscript.


Articles from Iranian Biomedical Journal are provided here courtesy of Pasteur Institute of Iran

RESOURCES